One of the major complications of the H1N1 and Covid-19 pandemic was severe acute lung injury, also called the acute respiratory distress syndrome (ARDS). This common lung injury and inflammation syndrome remains a major cause of ICU admissions, morbidity and mortality.
How do we better stratify patients with ARDS into distinct subgroups in the hopes of better understanding divergent outcomes? What role, if any, does the microbiome play in this process? Please join us for our Bench to Bedside Grand Rounds series given by Bryan McVerry, MD and Georgios Kitsios, MD, PhD as they discuss ARDS phenotypes and the microbiome.
Department of Medicine Grand Rounds
March 23, 2021
Georgios Kitsios, MD, PhD
Assistant Professor of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine
Director, ABIM Research Pathway, Internal Medicine Residency Program, UPMC
Bryan McVerry, MD
Associate Professor of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine
Associate Professor of Environmental and Occupational Health
Associate Professor of Clinical and Translational Science
University of Pittsburgh School of Medicine
View Presentation | CME Module